StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.43+0.01 (+0.70%)

Close on Nov 18, 2026Market cap $53.52MP/E –Yield –

Tenax Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Tenax Therapeutics's pe ratio was 155.5× on Jan 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024155.5×−105.6
2023Dec 29, 2023261.1×–

More Tenax Therapeutics figures

See a number that looks wrong?